$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2015 Q1 Form 10-K Financial Statement

#000114420415023047 Filed on April 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2013 Q4 2013
Revenue $113.00 $0.00 $1.249K
YoY Change -31.52%
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin 0.0%
Selling, General & Admin $10.00K $0.00 $30.00K
YoY Change 200.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.754K $0.00 $26.34K
YoY Change 140.07% 163.42%
Operating Profit -$1.829K $0.00 -$25.09K
YoY Change -53.08% 150.93%
Interest Expense $11.58K
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$5.461K
YoY Change -100.0%
Pretax Income -$11.58K $0.00 -$30.55K
YoY Change 173.96% 205.54%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.58K $0.00 -$30.55K
YoY Change 173.96% 118.87%
Net Earnings / Revenue -10250.44% -2446.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.972K $0.00 -$5.917K
COMMON SHARES
Basic Shares Outstanding 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $195.00 $525.00 $0.00
YoY Change -61.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $195.00 $525.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $195.00 $525.00 $0.00
YoY Change -61.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.129K $0.00
YoY Change
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00K $30.00K
YoY Change 50.0% 50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.17K $30.82K $30.00K
YoY Change 807.54% 54.08% 50.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $35.17K $30.82K $30.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $35.17K $30.82K $30.00K
YoY Change 807.54% 54.08% 50.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$34.97K -$30.29K -$30.00K
YoY Change
Total Liabilities & Shareholders Equity $195.00 $525.00 $0.00
YoY Change -61.0%

Cashflow Statement

Concept 2015 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$11.58K $0.00 -$30.55K
YoY Change 173.96% 118.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00K -$10.00K -$30.00K
YoY Change 200.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 0.000 20.00K
YoY Change
NET CHANGE
Cash From Operating Activities -20.00K -10.00K -30.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 20.00K 0.000 20.00K
Net Change In Cash 0.000 -10.00K -10.00K
YoY Change 0.0%
FREE CASH FLOW
Cash From Operating Activities -$20.00K -$10.00K -$30.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014Q2 dei Entity Public Float
EntityPublicFloat
315115 USD
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
773 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
1249 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36687 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26342 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
36687 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
26342 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-35914 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-25093 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5461 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-36244 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30554 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"><font style="text-decoration: underline; font-family: 'times new roman', times; font-size: 10pt;">Use of Estimates</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="text-decoration: underline; font-family: 'times new roman', times; font-size: 10pt;">Products and services, geographic areas and major customers</font></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</font></p> </div>
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2014 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45702 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31567 USD
CY2014Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
USD
CY2013Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
22000 USD
CY2014Q1 osok Related Party Accrued Interest
RelatedPartyAccruedInterest
1242 USD
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2014 osok Effective Income Tax Rate Reconciliation Operating Loss
EffectiveIncomeTaxRateReconciliationOperatingLoss
-0.39 pure
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
13500 USD
CY2014Q4 osok Related Party Forgiveness Of Note Payable Convertible Note Payable And Accrued Interest
RelatedPartyForgivenessOfNotePayableConvertibleNotePayableAndAccruedInterest
28146 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2013 osok Effective Income Tax Rate Reconciliation Operating Loss
EffectiveIncomeTaxRateReconciliationOperatingLoss
-0.39 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
45702 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31567 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14135 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9786 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-14135 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9786 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
6000 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
952 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1864 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35594 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30816 USD
CY2014Q4 us-gaap Liabilities
Liabilities
35594 USD
CY2013Q4 us-gaap Liabilities
Liabilities
30816 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
205 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9966 USD
CY2014 us-gaap Accretion Of Discount
AccretionOfDiscount
330 USD
CY2013 us-gaap Accretion Of Discount
AccretionOfDiscount
4000 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45577 USD
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
117185 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
80941 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-35389 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30291 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
525 USD
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
525 USD
CY2014Q4 us-gaap Assets
Assets
205 USD
CY2013Q4 us-gaap Assets
Assets
525 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22628 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014 osok Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
-3225 USD
CY2013 osok Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
1461 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-26173 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25093 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7000 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3225 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4000 USD
CY2014 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
USD
CY2013 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
13500 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25853 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
24500 USD
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-320 USD
CY2013 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-593 USD
CY2012Q4 us-gaap Cash
Cash
1118 USD
CY2014 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
28146 USD
CY2013 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
USD
CY2014 us-gaap Interest Paid
InterestPaid
USD
CY2013 us-gaap Interest Paid
InterestPaid
USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12966 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22628 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3225 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Notes Payable
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyNotesPayable
27921 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
22628 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Debt
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyDebt
952 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-17237 USD

Files In Submission

Name View Source Status
0001144204-15-023047-index-headers.html Edgar Link pending
0001144204-15-023047-index.html Edgar Link pending
0001144204-15-023047.txt Edgar Link pending
0001144204-15-023047-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
osok-20141231.xml Edgar Link completed
osok-20141231.xsd Edgar Link pending
osok-20141231_cal.xml Edgar Link unprocessable
osok-20141231_def.xml Edgar Link unprocessable
osok-20141231_lab.xml Edgar Link unprocessable
osok-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v406828_10k.htm Edgar Link pending
v406828_ex31.htm Edgar Link pending
v406828_ex32.htm Edgar Link pending